Lung Diseases

Step into a new era of healing at Infinity Stem Cells, where cutting-edge science meets the body’s innate potential. Our advanced cell regeneration therapies, centered on mesenchymal stem cells (MSCs), harness the transformative power of cellular renewal to address a wide range of conditions, restoring vitality and igniting wellness from within.

|

Lung Diseases

Biologic therapies for lung conditions aim to repair damaged lung tissue, calm inflammation, and improve oxygen exchange. By enhancing cell regeneration and mitochondrial function, these treatments offer new hope for patients with chronic or progressive respiratory diseases.

Common Conditions Treated

Chronic Obstructive Pulmonary Disease (COPD) – Persistent airway inflammation that limits airflow.
Pulmonary Fibrosis – Scarring of lung tissue that reduces elasticity.
Asthma – Ongoing airway inflammation causing breathing difficulties.
Acute Respiratory Distress Syndrome (ARDS) – Severe inflammation and fluid buildup in the lungs.
Post-COVID Lung Damage – Scarring and inflammation following COVID-19 infection.

Treatment Modalities

Exosome Therapy

Reduces inflammatory signals and promotes lung tissue regeneration.

Mesenchymal Stem Cell (MSC) Therapy

Repairs damaged tissues and modulates inflammation.

IV Infusion of Biologics

Provides systemic benefits for widespread lung involvement.

Nebulized Biologics

Inhaled for direct delivery to lung tissue.

Candidate Selection

Ideal Candidates:

People with chronic lung disease or long-term damage after viral illness
Those looking for alternatives to invasive procedures

Contraindications:

Patients with active respiratory infections
Individuals with advanced lung failure requiring mechanical ventilation

Procedure Overview

Preparation

Baseline Assessment – Pulmonary function tests (PFTs), chest imaging, and medical history review.
Informed Consent – Clear explanation of expected benefits, risks, and aftercare.
Administration –
- IV Infusion for systemic delivery
- Nebulized Therapy (experimental) for targeted lung application
Monitoring – Vital signs and lung function monitored during and after treatment.

Post-Treatment Care

Begin pulmonary rehab and breathing exercises.
Avoid exposure to smoke, pollution, or respiratory irritants.
Follow-up evaluations every 4–6 weeks to track lung function improvement.

Safety Measures

Strict sterile technique during biologic preparation and infusion.
Emergency preparedness for rare allergic reactions.
All biologics sourced from FDA-compliant laboratories.

Supporting Research

MSC Therapy for Pulmonary Fibrosis – Shown to reduce scarring and inflammation.
Exosomes in Respiratory Disease – Evidence supports their role in lung tissue repair and improved oxygen exchange.